Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Charts See Further Improvement

Published 04/18/2018, 10:25 AM
Updated 07/09/2023, 06:31 AM

McClellan 1-Day OB/OS Overbought

Opinion

The bulk of the indexes closed higher Tuesday with the one exception of the DJT declining. Internals were positive on the NYSE and NASDAQ as volumes rose on both exchanges from the prior session. A combination of resistance level violations and moves above the 50 DMA level occurred, further improving the current state of the charts. The data is largely neutral although the 1 day McClellan OB/OS Oscillators are now overbought. In spite of the OB/OS levels, we are maintaining our near term “positive” outlook for the major equity indexes at this time.

  • On the charts, the only index closing lower yesterday was the DJT (page 4). The rest rose with positive internals on higher trading volume. The DJI (page 2), COMPQX (page 3), MID (page 4) and RTY (page 5) all closed above their respective resistance levels while the SPX (page 2), DJI, COMPQX and NDX (page 3) closed back above their 50 DMAs. So we now find all if the index charts in near term uptrends and above their 50 DMAs, a condition not seen in several sessions. The cumulative advance/decline lines for the All Exchange, NYSE and NASDAQ are all positive and above their 50 DMAs as well. We would note, however, that recent strength has pushed all of the stochastic levels into overbought territory. Yet they are not actionable until bearish crossover signals appear. That has yet to occur.
  • The data is largely neutral but the McClellan 1 day OB/OS Oscillators are now overbought with the 21 day readings staying neutral (All Exchange:+67.48/+4.17 NYSE:+75.33/+15.68 NASDAQ:+60.69/-5.64). The Equity Put/Call Ratio (0.68), OEX P/C Ratio (1.22) and OpenInsider Buy/Sell Ratio (37.1) are all neutral with the Total P/C Ratio (contrary indicator) a bullish 0.96. Forward valuation of the SPX based on forward 12-month consensus earnings estimates is at a 16.8 multiple with the “rule of 20” implying fair value at a 17.2 multiple.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • In conclusion, while the 1-day OB/OS and stochastic levels are overbought and may dampen progress, we are shy of seeing signals that would cause us to alter our near term positive outlook for the major equity indexes.
  • Forward 12-month earnings estimates for the SPX from Bloomberg are $161.02 leaving a 5.95% forward earnings yield on a 16.8 forward multiple.
  • SPX: 2,646/2,711
  • DJI: 24,269/24,982
  • Nasdaq: 7,100/7,330
  • NDX: 6,584/6,825
  • DJT: 10,391/10,788
  • MID: 1,887/1,928
  • Russell: 1,532/1,593
  • VALUA: 6,007/6,167

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.